featured
Changes in Respiratory Symptoms During 48-Week Treatment With Inhaled Liposomal Ciprofloxacin in Bronchiectasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The European Respiratory Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Changes in Respiratory Symptoms During 48-Week Treatment With ARD-3150 (Inhaled Liposomal Ciprofloxacin) in Bronchiectasis: Results From the ORBIT-3 and -4 Studies
Eur. Respir. J. 2020 Oct 22;56(4)2000110, JD Chalmers, D Cipolla, B Thompson, AM Davis, A O'Donnell, G Tino, I Gonda, C Haworth, J FroehlichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.